A randomised controlled trial of the sirolimus-eluting biodegradable polymer ultra-thin Supraflex stent versus the everolimus-eluting biodegradable polymer SYNERGY stent for three-vessel coronary artery disease: rationale and design of the Multivessel TALENT trial
Publication year
2020Source
Eurointervention, 16, 12, (2020), pp. E997-e1004ISSN
Publication type
Article / Letter to editor
Display more detailsDisplay less details
Organization
Cardiology
Journal title
Eurointervention
Volume
vol. 16
Issue
iss. 12
Page start
p. E997
Page end
p. e1004
Subject
Radboudumc 16: Vascular damage RIHS: Radboud Institute for Health Sciences; Radboud University Medical CenterThis item appears in the following Collection(s)
- Academic publications [246764]
- Faculty of Medical Sciences [93461]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.